Ixekizumab OverviewIxekizumab (trade name Taltz; pronounced ix-ee-KIZ-ue-mab) is an injectable drug for the treatment of autoimmune diseases. Chemically, it is a humanized monoclonal antibody. The substance acts by blocking interleukin 17, reducing inflammation. The drug was developed by Eli Lilly and Co. and is approved for the treatment of plaque psoriasis in Europe and the US. Contents 1 Medical uses 2 Contraindications 3 Adverse effects 4 Overdose...
Read more Ixekizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ixekizumab
Recent Ixekizumab Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 80mg/ml